Loading…

Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors

Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularl...

Full description

Saved in:
Bibliographic Details
Published in:Cellular immunology 1998-10, Vol.189 (1), p.60-66
Main Authors: Kähne, Thilo, Neubert, Klaus, Faust, Jürgen, Ansorge, Siegfried
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83
cites cdi_FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83
container_end_page 66
container_issue 1
container_start_page 60
container_title Cellular immunology
container_volume 189
creator Kähne, Thilo
Neubert, Klaus
Faust, Jürgen
Ansorge, Siegfried
description Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularly, the necessity of catalytic dipeptidase activity for the costimulatory function of this molecule has been controversial. Here we provide evidence for a direct involvement of DPIV/CD26 in early phosphorylation mechanisms which are known to be essential in the signal transduction cascade of human T lymphocytes. We have found that DPIV-specific inhibitors (Lys[Z(NO2)]-thiazolidide and -piperidide) are capable of inducing intracellular tyrosine phosphorylation in resting human T cells. On the other hand, both inhibitors decreased the PMA-induced tyrosine phosphorylation in human T cells in a dose-dependent manner. Furthermore, a linkage between CD26 and the tyrosine kinase p56lckwas shown by inhibition of PMA-induced hyperphosphorylation of p56lckby means of DPIV-specific inhibitors. The data presented here suggest that the inhibition of DPIV enzymatic activity induces a inhibitory signal transmitted by tyrosine kinases which leads to a block in a PMA-induced downstream pathway. These results support the assumption that DPIV/CD26 is directly involved in early processes of T cell activation via its enzymatic activity.
doi_str_mv 10.1006/cimm.1998.1355
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17106860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0008874998913557</els_id><sourcerecordid>17106860</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83</originalsourceid><addsrcrecordid>eNp1kDtPwzAUhS0EKqWwsiFlYkt6nYdjj6gtUKkSlXislmPfqEZ5FDup1H9PolZsTHf4zjnS_Qi5pxBRADbXtq4jKgSPaJJlF2RKQUAYU5ZckikA8JDnqbgmN95_A1CaCpiQicgzzkQ2JauVctUx2O5av9-17lipzrZNsDpg0_lg3ZheowmKY7Dcrr_mi2XMwvc9altaPdCdLWzXOn9LrkpVebw73xn5fF59LF7DzdvLevG0CXWSQxdmseYlJEmmDC0KxYxBXVAwKU-R5bQsUhQMMY2Z1oaWJheYK0h4xlic5oonM_J42t279qdH38naeo1VpRpsey9pToFxBkMwOgW1a713WMq9s7VyR0lBjt7k6E2O3uTobSg8nJf7okbzFz-LGjg_cRzeO1h00muLzSDHOtSdNK39b_oXAlV72A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17106860</pqid></control><display><type>article</type><title>Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors</title><source>Elsevier</source><creator>Kähne, Thilo ; Neubert, Klaus ; Faust, Jürgen ; Ansorge, Siegfried</creator><creatorcontrib>Kähne, Thilo ; Neubert, Klaus ; Faust, Jürgen ; Ansorge, Siegfried</creatorcontrib><description>Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularly, the necessity of catalytic dipeptidase activity for the costimulatory function of this molecule has been controversial. Here we provide evidence for a direct involvement of DPIV/CD26 in early phosphorylation mechanisms which are known to be essential in the signal transduction cascade of human T lymphocytes. We have found that DPIV-specific inhibitors (Lys[Z(NO2)]-thiazolidide and -piperidide) are capable of inducing intracellular tyrosine phosphorylation in resting human T cells. On the other hand, both inhibitors decreased the PMA-induced tyrosine phosphorylation in human T cells in a dose-dependent manner. Furthermore, a linkage between CD26 and the tyrosine kinase p56lckwas shown by inhibition of PMA-induced hyperphosphorylation of p56lckby means of DPIV-specific inhibitors. The data presented here suggest that the inhibition of DPIV enzymatic activity induces a inhibitory signal transmitted by tyrosine kinases which leads to a block in a PMA-induced downstream pathway. These results support the assumption that DPIV/CD26 is directly involved in early processes of T cell activation via its enzymatic activity.</description><identifier>ISSN: 0008-8749</identifier><identifier>EISSN: 1090-2163</identifier><identifier>DOI: 10.1006/cimm.1998.1355</identifier><identifier>PMID: 9758695</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Calcium - metabolism ; CD26 ; CD3 Complex - metabolism ; Cyclic AMP - metabolism ; Dipeptidyl Peptidase 4 - metabolism ; dipeptidyl peptidase IV ; Humans ; Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism ; Lysine - analogs &amp; derivatives ; Lysine - pharmacology ; Mitogens - pharmacology ; Phosphorylation ; Piperidines - pharmacology ; Protease Inhibitors - pharmacology ; Protein Kinase C - metabolism ; protein tyrosine phosphorylation ; T-Lymphocytes - metabolism ; Tetradecanoylphorbol Acetate - pharmacology ; Thiazoles - pharmacology ; Tyrosine - metabolism</subject><ispartof>Cellular immunology, 1998-10, Vol.189 (1), p.60-66</ispartof><rights>1998 Academic Press</rights><rights>Copyright 1998 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83</citedby><cites>FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9758695$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kähne, Thilo</creatorcontrib><creatorcontrib>Neubert, Klaus</creatorcontrib><creatorcontrib>Faust, Jürgen</creatorcontrib><creatorcontrib>Ansorge, Siegfried</creatorcontrib><title>Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors</title><title>Cellular immunology</title><addtitle>Cell Immunol</addtitle><description>Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularly, the necessity of catalytic dipeptidase activity for the costimulatory function of this molecule has been controversial. Here we provide evidence for a direct involvement of DPIV/CD26 in early phosphorylation mechanisms which are known to be essential in the signal transduction cascade of human T lymphocytes. We have found that DPIV-specific inhibitors (Lys[Z(NO2)]-thiazolidide and -piperidide) are capable of inducing intracellular tyrosine phosphorylation in resting human T cells. On the other hand, both inhibitors decreased the PMA-induced tyrosine phosphorylation in human T cells in a dose-dependent manner. Furthermore, a linkage between CD26 and the tyrosine kinase p56lckwas shown by inhibition of PMA-induced hyperphosphorylation of p56lckby means of DPIV-specific inhibitors. The data presented here suggest that the inhibition of DPIV enzymatic activity induces a inhibitory signal transmitted by tyrosine kinases which leads to a block in a PMA-induced downstream pathway. These results support the assumption that DPIV/CD26 is directly involved in early processes of T cell activation via its enzymatic activity.</description><subject>Calcium - metabolism</subject><subject>CD26</subject><subject>CD3 Complex - metabolism</subject><subject>Cyclic AMP - metabolism</subject><subject>Dipeptidyl Peptidase 4 - metabolism</subject><subject>dipeptidyl peptidase IV</subject><subject>Humans</subject><subject>Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism</subject><subject>Lysine - analogs &amp; derivatives</subject><subject>Lysine - pharmacology</subject><subject>Mitogens - pharmacology</subject><subject>Phosphorylation</subject><subject>Piperidines - pharmacology</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Protein Kinase C - metabolism</subject><subject>protein tyrosine phosphorylation</subject><subject>T-Lymphocytes - metabolism</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Thiazoles - pharmacology</subject><subject>Tyrosine - metabolism</subject><issn>0008-8749</issn><issn>1090-2163</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNp1kDtPwzAUhS0EKqWwsiFlYkt6nYdjj6gtUKkSlXislmPfqEZ5FDup1H9PolZsTHf4zjnS_Qi5pxBRADbXtq4jKgSPaJJlF2RKQUAYU5ZckikA8JDnqbgmN95_A1CaCpiQicgzzkQ2JauVctUx2O5av9-17lipzrZNsDpg0_lg3ZheowmKY7Dcrr_mi2XMwvc9altaPdCdLWzXOn9LrkpVebw73xn5fF59LF7DzdvLevG0CXWSQxdmseYlJEmmDC0KxYxBXVAwKU-R5bQsUhQMMY2Z1oaWJheYK0h4xlic5oonM_J42t279qdH38naeo1VpRpsey9pToFxBkMwOgW1a713WMq9s7VyR0lBjt7k6E2O3uTobSg8nJf7okbzFz-LGjg_cRzeO1h00muLzSDHOtSdNK39b_oXAlV72A</recordid><startdate>19981010</startdate><enddate>19981010</enddate><creator>Kähne, Thilo</creator><creator>Neubert, Klaus</creator><creator>Faust, Jürgen</creator><creator>Ansorge, Siegfried</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>19981010</creationdate><title>Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors</title><author>Kähne, Thilo ; Neubert, Klaus ; Faust, Jürgen ; Ansorge, Siegfried</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Calcium - metabolism</topic><topic>CD26</topic><topic>CD3 Complex - metabolism</topic><topic>Cyclic AMP - metabolism</topic><topic>Dipeptidyl Peptidase 4 - metabolism</topic><topic>dipeptidyl peptidase IV</topic><topic>Humans</topic><topic>Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism</topic><topic>Lysine - analogs &amp; derivatives</topic><topic>Lysine - pharmacology</topic><topic>Mitogens - pharmacology</topic><topic>Phosphorylation</topic><topic>Piperidines - pharmacology</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Protein Kinase C - metabolism</topic><topic>protein tyrosine phosphorylation</topic><topic>T-Lymphocytes - metabolism</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Thiazoles - pharmacology</topic><topic>Tyrosine - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kähne, Thilo</creatorcontrib><creatorcontrib>Neubert, Klaus</creatorcontrib><creatorcontrib>Faust, Jürgen</creatorcontrib><creatorcontrib>Ansorge, Siegfried</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Cellular immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kähne, Thilo</au><au>Neubert, Klaus</au><au>Faust, Jürgen</au><au>Ansorge, Siegfried</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors</atitle><jtitle>Cellular immunology</jtitle><addtitle>Cell Immunol</addtitle><date>1998-10-10</date><risdate>1998</risdate><volume>189</volume><issue>1</issue><spage>60</spage><epage>66</epage><pages>60-66</pages><issn>0008-8749</issn><eissn>1090-2163</eissn><abstract>Dipeptidyl peptidase IV (DPIV, CD26) is known to be involved in the regulation of T lymphocyte and NK cell activation and proliferationin vitro.The molecular events of lymphocyte activation mediated by this ectopeptidase as well as their physiological ligands are only partly established. Particularly, the necessity of catalytic dipeptidase activity for the costimulatory function of this molecule has been controversial. Here we provide evidence for a direct involvement of DPIV/CD26 in early phosphorylation mechanisms which are known to be essential in the signal transduction cascade of human T lymphocytes. We have found that DPIV-specific inhibitors (Lys[Z(NO2)]-thiazolidide and -piperidide) are capable of inducing intracellular tyrosine phosphorylation in resting human T cells. On the other hand, both inhibitors decreased the PMA-induced tyrosine phosphorylation in human T cells in a dose-dependent manner. Furthermore, a linkage between CD26 and the tyrosine kinase p56lckwas shown by inhibition of PMA-induced hyperphosphorylation of p56lckby means of DPIV-specific inhibitors. The data presented here suggest that the inhibition of DPIV enzymatic activity induces a inhibitory signal transmitted by tyrosine kinases which leads to a block in a PMA-induced downstream pathway. These results support the assumption that DPIV/CD26 is directly involved in early processes of T cell activation via its enzymatic activity.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>9758695</pmid><doi>10.1006/cimm.1998.1355</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-8749
ispartof Cellular immunology, 1998-10, Vol.189 (1), p.60-66
issn 0008-8749
1090-2163
language eng
recordid cdi_proquest_miscellaneous_17106860
source Elsevier
subjects Calcium - metabolism
CD26
CD3 Complex - metabolism
Cyclic AMP - metabolism
Dipeptidyl Peptidase 4 - metabolism
dipeptidyl peptidase IV
Humans
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) - metabolism
Lysine - analogs & derivatives
Lysine - pharmacology
Mitogens - pharmacology
Phosphorylation
Piperidines - pharmacology
Protease Inhibitors - pharmacology
Protein Kinase C - metabolism
protein tyrosine phosphorylation
T-Lymphocytes - metabolism
Tetradecanoylphorbol Acetate - pharmacology
Thiazoles - pharmacology
Tyrosine - metabolism
title Early Phosphorylation Events Induced by DPIV/CD26-Specific Inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A29%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20Phosphorylation%20Events%20Induced%20by%20DPIV/CD26-Specific%20Inhibitors&rft.jtitle=Cellular%20immunology&rft.au=K%C3%A4hne,%20Thilo&rft.date=1998-10-10&rft.volume=189&rft.issue=1&rft.spage=60&rft.epage=66&rft.pages=60-66&rft.issn=0008-8749&rft.eissn=1090-2163&rft_id=info:doi/10.1006/cimm.1998.1355&rft_dat=%3Cproquest_cross%3E17106860%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c370t-52c8f0335ad1bba6ddecb10d484e671fb4e96ee426ccd1fd79e7a038566247a83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17106860&rft_id=info:pmid/9758695&rfr_iscdi=true